Amylyx Pharmaceutical
ID: 5330236Amylyx Pharmaceutical is a combination of existing products founded in 2013 by Justin Klee.
2
Funding Rounds
$140.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Co*** | - | - | |
| Ju**** Kl** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Co*** | - | - | |
| Ju**** Kl** | - | - | |
| Pa** Fo****** | - | - | |
| Is*** Ch*** | - | - | - |
| Da**** Qu*** | - | - |
Funding
Funding series
Funding Series Analysis
The company Amylyx Pharmaceutical has raised a total of $140m in funding over 2 rounds.
Key Insights:
- Amylyx Pharmaceutical Series C round, July 2021: $135m
- Amylyx Pharmaceutical Series A round, August 2016: $5m
Industries
Amylyx Pharmaceutical is active in the following industries: